HighTower Advisors’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.6K Hold
51,442
﹤0.01% 3752
2025
Q4
$113K Hold
51,442
﹤0.01% 3486
2025
Q3
$81.8K Buy
51,442
+521
+1% +$676 ﹤0.01% 3567
2025
Q2
$82.5K Buy
50,921
+10,000
+24% +$16.2K ﹤0.01% 3499
2025
Q1
$48.7K Buy
40,921
+15,000
+58% +$23.9K ﹤0.01% 3456
2024
Q4
$53.4K Buy
25,921
+10,921
+73% +$25.4K ﹤0.01% 3450
2024
Q3
$38K Buy
+15,000
New +$48.9K ﹤0.01% 3443

Other funds holding GUTS

HighTower Advisors's GUTS Position: Q1 2026 in Review

HighTower Advisors held its Fractyl Health (GUTS) position steady in Q1 2026 at 51,442 shares worth $23.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3752.

HighTower Advisors first reported a position in GUTS in Q3 2024 and has held it in 7 quarters since. The position peaked at $113K in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • HighTower Advisors held 51,442 shares of Fractyl Health worth $23.6K as of Q1 2026.
  • HighTower Advisors left its Fractyl Health share count unchanged in Q1 2026.
  • Fractyl Health made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3752 holding.
  • HighTower Advisors first reported a position in Fractyl Health in Q3 2024 and has held it in 7 quarters since.
  • HighTower Advisors's Fractyl Health position peaked at $113K in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.